These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33787270)

  • 61. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
    Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiation-guided drug delivery to mouse models of lung cancer.
    Hariri G; Yan H; Wang H; Han Z; Hallahan DE
    Clin Cancer Res; 2010 Oct; 16(20):4968-77. PubMed ID: 20802016
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
    Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
    Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
    Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
    J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.
    Ait-Oudhia S; Straubinger RM; Mager DE
    Pharm Res; 2012 Oct; 29(10):2833-44. PubMed ID: 22588463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
    Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
    Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
    J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Implications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugs.
    Elzoghby AO; Elgohary MM; Kamel NM
    Adv Protein Chem Struct Biol; 2015; 98():169-221. PubMed ID: 25819280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human Serum Albumin as Multifunctional Nanocarrier for Cancer Therapy.
    Zeeshan F; Madheswaran T; Panneerselvam J; Taliyan R; Kesharwani P
    J Pharm Sci; 2021 Sep; 110(9):3111-3117. PubMed ID: 33989679
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M; Kendall J; Denny W; Garg S
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q; Ching AK; Leung WK; Szeto CY; Ho SM; Chan PK; Yuan YF; Lai PB; Yeo W; Wong N
    Int J Oncol; 2011 Mar; 38(3):721-31. PubMed ID: 21240457
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?
    Sparreboom A; Baker SD; Verweij J
    J Clin Oncol; 2005 Nov; 23(31):7765-7. PubMed ID: 16258080
    [No Abstract]   [Full Text] [Related]  

  • 77. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reinvention of chemotherapy: drug conjugates and nanoparticles.
    Nguyen-Ngoc T; Raymond E
    Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Albumin-bound Paclitaxel: in metastatic breast cancer.
    Robinson DM; Keating GM
    Drugs; 2006; 66(7):941-8. PubMed ID: 16740010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
    Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
    Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.